PhytoSquene® now available for clinical and commercial use Adjuvant component for parenteral drug delivery applications Provides batch-to-batch consistency, quality and purity and reduces reliance on animal-derived materials Evonik’s non-animal-derived squalene… Read More
VANCOUVER, BC, TORONTO, ON, and MONTREAL, QC — adMare BioInnovations is proud to launch the enhanced adMare Community, a revamped online platform with several new, more advanced and efficient features, dedicated… Read More
Risk of death was reduced by 53% in patients treated with enfortumab vedotin plus pembrolizumab compared to chemotherapy Enfortumab vedotin plus pembrolizumab improved median overall survival by more than 15… Read More
TIVDAK demonstrated superior overall survival, progression-free survival and objective response rate compared to chemotherapy in late-breaking results presented at ESMO 2023 congress Results from innovaTV 301 intended to serve as… Read More
Combination of masofaniten plus enzalutamide continues to be well tolerated with deep and durable reductions in PSA in patients with mCRPC Across all cohorts of patients including those recently enrolled… Read More
